Browse > Article
http://dx.doi.org/10.15204/jkobgy.2019.32.1.108

6 Cases of Polycystic Ovarian Disease Patients Recovering Ovulatory Menstrual Cycle with the Korean Medical Treatment : a Case Report  

Hwangbo, Su-Min (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Hwang, Deok-Sang (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Lee, Jin-Moo (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Lee, Chang-Hoon (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Jang, Jun-Bock (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.32, no.1, 2019 , pp. 108-126 More about this Journal
Abstract
Objectives: The purpose of this study is to report the effect of Korean medical treatment in case of irregular menstruation (amenorrhea, oligomenorrhea) patients due to Polycystic ovarian syndrome (PCOS). There are some case reports about effectiveness of the Korean medical treatment to this disease, but cases are still deficient. And this case has significance for ascertaining PCOS patients' ovulation. Methods: 6 Amenorrhea or oligomenorrhea patients with PCOS were treated with Korean medical treatment (herbal medicine, moxibustion, acupuncture) at least 3 months. We estimated the effects of treatments through the change of menstrual pattern. Also, we checked follicles by ultrasonography for ovulation. Results: All patients recovered ovulatory menstrual cycle after taking Korean medical treatment for 3~9 months. Conclusions: These cases show the Korean medical treatment is effective on PCOS patients with irregular menstruation by recovering ovulatory menstrual cycle.
Keywords
Polycystic Ovarian Syndrome; Ovulatory Menstrual Cycle; Irregular Menstruation; Herbal Medicine; Korean Medical Treatment;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Balen AH, et al. Ultrasound assessment of the polycystic ovary : international consensus definitions. Hum Reprod Update 2003;9(6):505-14.   DOI
2 Polson DW, et al. Polycystic ovaries--a common finding in normal women. Lancet 1988;1(8590):870-2.   DOI
3 Azziz R, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237-45.   DOI
4 Waldstreicher J, et al. Hyperfunction of the hypothalamic -pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab. 1988;66(1):165-72.   DOI
5 Imse V, et al. Comparision of luteinizing hormonepulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays. J Clin Endocrinol Metab. 1992;74(5):1053-61.   DOI
6 Tummon I, et al. Polystic ovaries and ovarian hyperstimulation syndrome: a systematic review. Acta obstetricia et gynecologica Scandinavica 2005; 84(7):611-6.   DOI
7 Li Y, et al. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: Evidence from a meta-analysis. Fertility and sterility. 2011;96(2):452-8.   DOI
8 Coffey S, Bano G, Mason HD. Health -related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36(SF-36). Gynecological Endocrinology. 2006;22(2):80-6.   DOI
9 Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: A comprehensive investigation. Fertility and Sterility. 2010;93(7):2421-3.   DOI
10 Dongeuibogam compilation committee. Dongeuibogam. Seoul:BupIn publisher co. 1999:361-71, 1584-8.
11 Yoon SY, Kang MJ. Clinical Study of Oriental Medicine Treatment for Polycystic Ovarian Disease. Korea Journal of Obstetrics and Gynecology. 2000;13(2):437-51.
12 Seop Gye. Seopcheonsayeogwa. Seoul: Daesung publisher co. 1995:14-5, 70, 101.
13 Shin MG. Clinical Herbology Education. Seoul:Sam Gwang publisher, 2000:172-4, 180-2, 469-71, 477-8, 483, 587-8, 649-52, 744-7, 819-21.
14 Jang JY. Jingyuequanshu. Seoul:Daesung publisher co. 1992:423.
15 Herbology professors in colleges of Korean Traditional Medicine. Herbology. Seoul:Younglim co. 1994:302-4, 537-8, 556-7, 568-9, 578-81, 596-7, 626-7.
16 Ahn KH, et al. Effects of Guisin-hwan on the Ovulation and Ovary in Rats. The Journal of Oriental Obstetrics & Gynecology. 2005;18(3):1-16.
17 Cho WY, Park KH. Study on thermographic change of DITI by acupuncture on sakwan point. The Korean journal of oriental medical thermology. 2015; 4(1):45-53.
18 Kwon SR, et al. Effects of electro acupuncture on Samuumgyo (SP-6). Chagung (CA-111) on polycystic ovary in rats. Korean Journal of Obstetrics and Gynecology. 2003;16(2):76-86.
19 Min EG. Recent Clinical Review : The polycystic ovary syndrome. Korean Journal of Obstetrics and Gynecology. 2008;51(8):805-19.
20 Goodarzi MO, et al, Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature reviews Endocrinology. 2011;7(4):219-31.   DOI
21 March WA, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction. 2010;25(2):544-51.   DOI
22 Health Insurance Review & Assessment Service [Internet]. [cite 2018 July 2]. Available from: http://opendata.hira. or.kr/op/opc/olap4thDsInfo.do
23 Kim DI, et al. Literature Review for polycystic ovary syndrome. Korean Journal of Obstetrics and Gynecology. 1997;10(1):73-91.
24 The Society of Korean Medicine Obstetrics and Gynecology. Oriental Obstetrics & Gynecology Ha. 1st edition. Seoul :Euiseongdang. 2012:225-33.
25 Lo JC, et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism. 2006;91(4):1357-63.   DOI
26 Korean society of Obstetrics and gynecology. Gynecology. 5th edition. Seoul:Korea medical book. 2015:488-500.
27 Solomon et al. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes millitus. JAMA : the journal of the American Medical Association. 2001;286(19):2421-6.   DOI
28 Dokras A, et al. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstetrics and gynecology. 2005;106(1):131-7.   DOI
29 Pourteymour Fard Tabrizi F, et al. Metabolic syndrome and its characteristics among reproductive-aged women with polycystic ovary syndrome: A cross -sectional study in northwest Iran. International Journal of Fertility and Sterility. 2013;6(4):244-9.
30 Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Human Reproduction. 2012;27(5):1327-31.   DOI
31 Homburg R. Pregnancy complications in PCOS. Best practice and research clinical endocrinology and metabolism. 2006;20(2):281-92.   DOI
32 Bjercke S, et al. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecologic and Obstetric Investigation. 2002;54(2):94-8.   DOI
33 Yeo EJ, et al. Effects of Pinelliae Rhizoma(PR) on Ovarian Tissue in Polycystic Ovary Syndrome(PCOS) Rats. The Journal of Oriental Obstetrics & Gynecology. 2012;25(2):66-77.
34 Kim JD, et al. Effects of Ojeok-san on the Maturation of Follicles and NGF Expression in Rats with Estradiol Valerate-induced Polycystic Ovaries. Korean Journal of Obstetrics and Gynecology. 2011;24(1):27-41.
35 Yang DS, et al. Effects of Cyperi Rhizoma (CR) on the Polycystic Ovaries Induced by Estradiol Valerate in Rats. Korean Journal of Obstetrics and Gynecology. 2010;23(4):35-46.
36 Ryu KJ, Cho SH. Effects of Angelicae Gigantis Radix on Gene Expression of Ovarian Tissue in Polycystic Ovary Syndrome Rats. Korean Journal of Obstetrics and Gynecology. 2011;24(3):28-47.
37 Gu HJ, Cho SH. Effects of Gleditsiae Spina(GS) on the Polycystic Ovary Induced by Estradiol Valerate in Rats. Korean Journal of Obstetrics and Gynecology. 2010;23(2):71-84.
38 Yun MH, et al. Effects of Gaeullijin-tang on the Progression of the Estradiol Valerate-induced Polycystic Ovaries in Rats. Korean Journal of Obstetrics and Gynecology. 2010;23(2):1-19.
39 Nam EJ, et al. Effects of Jeongkyeong -tang on the Estradiol Valerate-induced Polycystic Ovary in Rats. Korean Journal of Obstetrics and Gynecology. 2007;20(1):99-113.
40 Yang SJ, et al. Effects of ChangbuDodam -tang on the Polycystic Ovaries Induced by Estradiol Valerate in Rats. Korean Journal of Obstetrics and Gynecology. 2002;15(2):1-11.
41 Bae SJ, et al. Effects of Hyeolbuchukeo -tang on the Estradiol Valerate-induced Polycystic Ovaries and the Conception of Rats. Korean Journal of Obstetrics and Gynecology. 2012;25(2):43-65.
42 Kim HJ, et al. Effects of Changbuyeukgun-tang on the Estradiol Valerate-induced Polycystic Ovaries in Rats. Korean Journal of Obstetrics and Gynecology. 2008;21(2):1-16.
43 Lee JH, et al. Case Report of 20 Amenorrhea or Oligomenorrhea Patients due to Polycystic Ovarian Syndrome. J Korean Obstet Gynecol. 2016;29(3): 47-56.   DOI
44 Lee YK, et al. Effects of Gwibi-tang on the Estradiol Valerate-induced Polycystic Ovaries in Rat. J Korean Obstet Gynecol. 2008;21(3):60-74.
45 Oh TG, et al. Clinical Study for the One Case that Diagnosed Polycystic Ovarian Disease. Korean Journal of Obstetrics and Gynecology. 2008; 21(2):284-91.
46 Kim JY, et al. Clinical Study for the One Case that Diagnosed Polycystic Ovarian Disease. J Korean Obstet Gynecol. 2014;27(3):151-7.   DOI
47 Queenan JT, et al. Ultrasound scanning of ovaries to detect ovulation in women. Fertil Steril. 1980;34(2):99-105.   DOI
48 Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In : Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic Ovary Syndrome. 3rd ed. Boston:Blackwell Scientific Publications. 1992:377-84.
49 Goldzieher JW, Fariss B. The polycystic ovary. VII. Intractable uterine bleeding and endometrial hyperplasia possibly related to an extraovarian source of oestrogen. Acta Endocrinol(Copenh). 1967;54(3):452-66.   DOI
50 The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.   DOI
51 Yoo YK, et al. Effects of Shingihwanhapchangbudodam-tang on the Estradiol Valerate-induced Polycystic Ovary in Rats. Korean Journal of Obstetrics and Gynecology. 2007;20(1):84-98.